Healthpeak Properties, Inc.

NYSE:DOC Stock Report

Market Cap: US$15.4b

Healthpeak Properties Future Growth

Future criteria checks 0/6

Healthpeak Properties's earnings are forecast to decline at 22.3% per annum while its annual revenue is expected to grow at 5.7% per year. EPS is expected to decline by 21.2% per annum. Return on equity is forecast to be 2.3% in 3 years.

Key information

-22.3%

Earnings growth rate

-21.2%

EPS growth rate

Health Care REITs earnings growth22.8%
Revenue growth rate5.7%
Future return on equity2.3%
Analyst coverage

Good

Last updated22 Nov 2024

Recent future growth updates

Recent updates

Healthpeak: Potential Upside Still Exists, But Don't Expect Much

Oct 21

Healthpeak: Missing The Boat Above $20/Share

Jul 18

Healthpeak Properties: A 6.1% Yielding Healthcare Trust With Upside

Jul 09

Healthpeak Q1 - The "Best" In The Space With A 15% Upside

May 14

HealthPeak Properties: A Quality Healthcare REIT That Should Get Back To Dividend Growth

Apr 12

Healthpeak Properties: Undervalued With Strong Fundamentals

Feb 22

Healthpeak Opportunistically Cheap As Supply Moderates

Dec 13

Healthpeak Properties: 7.2% Yielding SWAN

Oct 29

Healthpeak Properties: A Safe 6.9% Yield

Oct 17

Healthpeak Is Both Undervalued And Undercovered - And A 'Buy'

Aug 10

Healthpeak Properties: 6% Yield, Profit From Market Absurdity

Jul 06

Healthpeak Properties FFO of $0.44 beats by $0.01, revenue of $524.47M beats by $5.62M

Feb 07

Healthpeak Properties declares $0.30 dividend

Feb 01

Healthpeak prices $400M notes offering

Jan 09

Healthpeak Properties Q3 2022 Earnings Preview

Oct 31

Healthpeak Properties: A Smart Income Stock Flying Under The Radar

Sep 19

Healthpeak Properties: There Are Still Better Prospects Right Now

Jul 06

Earnings and Revenue Growth Forecasts

NYSE:DOC - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20262,9611696181,4657
12/31/20252,8371606731,38911
12/31/20242,6722847071,31612
9/30/20242,5563091,0181,018N/A
6/30/20242,412287953953N/A
3/31/20242,262193935935N/A
12/31/20232,181304956956N/A
9/30/20232,152239932932N/A
6/30/20232,116530922922N/A
3/31/20232,088543880880N/A
12/31/20222,061495900900N/A
9/30/20222,020514917917N/A
6/30/20221,981213885885N/A
3/31/20221,939312867867N/A
12/31/20211,896117795795N/A
9/30/20211,84568790790N/A
6/30/20211,787-17798798N/A
3/31/20211,719-125786786N/A
12/31/20201,645144758758N/A
9/30/2020988326757757N/A
6/30/20201,102311785785N/A
3/31/20201,185240783783N/A
12/31/20191,240159846846N/A
9/30/20191,908831844844N/A
6/30/20191,826976790790N/A
3/31/20191,8041,080811811N/A
12/31/20181,191822849849N/A
9/30/20181,848169842842N/A
6/30/20181,84662N/A855N/A
3/31/20181,835-8N/A850N/A
12/31/20171,848413N/A847N/A
9/30/20171,945549N/A853N/A
6/30/20172,022599N/A979N/A
3/31/20172,101774N/A1,139N/A
12/31/20162,129361N/A1,214N/A
9/30/20161,655384N/A1,353N/A
6/30/20161,781456N/A1,295N/A
3/31/20161,850427N/A1,261N/A
12/31/20151,940139N/A1,216N/A
9/30/20152,478235N/A1,233N/A
6/30/20152,418367N/A1,235N/A
3/31/20152,347421N/A1,232N/A
12/31/20141,637255N/A1,249N/A
9/30/20142,193927N/A1,188N/A
6/30/20142,143903N/A1,185N/A
3/31/20142,119895N/A1,182N/A
12/31/20132,100895N/A1,149N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: DOC's earnings are forecast to decline over the next 3 years (-22.3% per year).

Earnings vs Market: DOC's earnings are forecast to decline over the next 3 years (-22.3% per year).

High Growth Earnings: DOC's earnings are forecast to decline over the next 3 years.

Revenue vs Market: DOC's revenue (5.7% per year) is forecast to grow slower than the US market (8.9% per year).

High Growth Revenue: DOC's revenue (5.7% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: DOC's Return on Equity is forecast to be low in 3 years time (2.3%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y